NNE Pharmaplan receives international honour
The honour was presented to NNE Pharmaplan by Robert P. Best, ISPE's President and CEO, at the Society's 2008 Annual Meeting held on 26-29 October in Boca Raton, Florida, USA.
"On behalf of ISPE, I would like to congratulate NNE Pharmaplan on receiving the Company of the Year Award presented for its exceptional support of the Society. NNE Pharmaplan has been a strong supporter of the Society in 2008 and for many years prior, generously encouraging the participation of many of its employees on ISPE international and Affiliate and Chapter committees both as members and Chairs. NNE Pharmaplan has heavily supported the Society in our quest to be a catalyst for change for the industry. We are grateful for the time and dedication NNE Pharmaplan has demonstrated in supporting the Society," said Robert P. Best.
Among previous receivers of the prestigious ISPE Company of the Year award are companies like Pfizer (2007), GSK (2006) and Genentech (2005).
"This is one of the most attractive awards in our industry and a great achievement for NNE Pharmaplan. To receive this recognition from a highly esteemed organisation as ISPE further enhances our position as the leading international supplier of projects, engineering and consulting services to the pharma and biotech industries," said Morten Nielsen, Chief Operating Officer (COO) at NNE Pharmaplan.
"It is at the same time an important acknowledgement of the valuable efforts made by our 1500 dedicated people around the world, continuously working to improve methods and technologies for the manufacture of pharmaceutical products and thus improving the lives of people," Morten Nielsen said.
ISPE is the Society of choice for 25,000 pharmaceutical science and manufacturing professionals in 90 countries. Founded in 1980, ISPE aims to be the catalyst for engineering pharmaceutical innovation by providing members with opportunities to develop technical knowledge, exchange practical experience, and collaborate with global regulatory agencies and industry leaders.
NNE Pharmaplan is the world's leading engineering and consulting company focused exclusively on the pharma and biotech industries.
NNE Pharmaplan covers the entire pharmaceutical supply chain from product development to manufacturing with know-how, expertise and well-proven solutions founded on more than 80 years of experience in the life science industry.
Headquartered in Denmark, NNE Pharmaplan employs more than 1500 people at over 20 locations around the world, offering global reach and local knowledge in all major pharma and biotech markets. NNE Pharmaplan is a company in the Novo Group.